{"count": 1, "results": [{"_id": "34416879", "pmid": 34416879, "pmcid": "PMC8377455", "title": "Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial", "journal": "BMC Endocr Disord", "authors": ["Alipour S", "Abedi M", "Saberi A", "Maleki-Hajiagha A", "Faiz F", "Shahsavari S", "Eslami B"], "date": "2021-08-20T00:00:00Z", "doi": "10.1186/s12902-021-00824-4", "meta_date_publication": "2021 Aug 20", "meta_volume": "21", "meta_issue": "1", "meta_pages": "169", "score": 50279.04, "text_hl": "The most important positive findings can be briefly interpreted as: (1) Significant enlargement was less probable in @<m>DISEASE_Dianzani_autoimmune_lymphoproliferative_syndrome</m> @DISEASE_MESH:C535950 @@@FAs@@@ under @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ treatment. (2) In @SPECIES_9606 @@@women@@@ with multiple @<m>DISEASE_Dianzani_autoimmune_lymphoproliferative_syndrome</m> @DISEASE_MESH:C535950 @@@FAs@@@, MF increased more than four-fold the probability of a safe course for all the masses of a @SPECIES_9606 @@@patient@@@ by decreasing the chance for significant enlargement. (3) FAs under @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ treatment had a two-fold size decrement compared with those under placebo. (4) For the largest @DISEASE_Fibroadenoma @DISEASE_MESH:D018226 @@@FA@@@ of each @SPECIES_9606 @@@patient@@@, size reduction was more frequent and enlargement was less frequent with MF than with placebo. (5) @SPECIES_9606 @@@Women@@@ receiving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ had experienced a two-fold regression of FA size in comparison with the placebo group in all @DISEASE_Fibroadenoma @DISEASE_MESH:D018226 @@@fibroadenoma@@@. (6) The rate of disappearance of @<m>DISEASE_Dianzani_autoimmune_lymphoproliferative_syndrome</m> @DISEASE_MESH:C535950 @@@FAs@@@ was higher in largest and smallest @DISEASE_Fibroadenoma @DISEASE_MESH:D018226 @@@fibroadenoma@@@ under @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MF@@@ treatment in @SPECIES_9606 @@@women@@@ with multiple lesions.", "citations": {"NLM": "Alipour S, Abedi M, Saberi A, Maleki-Hajiagha A, Faiz F, Shahsavari S, Eslami B. Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial BMC Endocr Disord. 2021 Aug 20;21(1):169. PMID: 34416879", "BibTeX": "@article{34416879, title={Metformin as a new option in the medical management of breast fibroadenoma; a randomized clinical trial}, author={Alipour S and Abedi M and Saberi A and Maleki-Hajiagha A and Faiz F and Shahsavari S and Eslami B}, journal={BMC Endocr Disord}, volume={21}, number={1}, pages={169}}"}}]}